About
MemoBoost is developing a pioneering drug treatment designed to inhibit the onset of dementia. The companys technology is based on research into the scientific foundations of learning and memory in the brain. MemoBoost is headed by Prof. Edi Barkai of the University of Haifas Sagol Department of Neurobiology and the head of the Laboratory for Neurobiology of Learning and Memory. Prof. Barkai is on the path to developing a cognitive/learning-enhancing drug that may counter the cognitive deficits suffered by dementia patients. Prof. Barkais research has identified a specific receptor in the brain, in the mGluR family, which inhibits learning when its excitability is blocked and improves learning when its excitability is consistently enhanced. Using a research compound that activates this receptor, Prof. Barkais group has successfully shown that learning is significantly enhanced in a validated animal model of learning. The compound is currently being modified and tested in order to develop a drug that will serve as a potent cognitive enhancer to tackle the onset of dementia and other cognitive deficits.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MemoBoost's primary focus?
- MemoBoost is developing a pioneering drug treatment designed to inhibit the onset of dementia.
- When was MemoBoost founded?
- MemoBoost was founded in March 2016.
- What is the current operational status of MemoBoost?
- MemoBoost is currently inactive, having ceased to operate in May 2024.
- Who leads the research and development at MemoBoost?
- Prof. Edi Barkai of the University of Haifa's Sagol Department of Neurobiology heads MemoBoost and its research.
- What is the scientific basis of MemoBoost's technology?
- MemoBoost's technology is based on research into the scientific foundations of learning and memory in the brain, specifically targeting a receptor in the mGluR family.
- Has MemoBoost received any funding?
- Yes, MemoBoost received Seed funding in June 2016 from Carmel Innovation Fund. For full financing history, refer to startupim.
- Where is MemoBoost headquartered?
- MemoBoost is headquartered in Haifa, Israel.
- What is the employee count of MemoBoost?
- MemoBoost has between 1 and 10 employees, with an exact count of 6.